Reduction in hypophyseal growth hormone and prolactin expression due to deficiency in ghrelin receptor signaling is associated with Pit-1 suppression: Relevance to the immune system

• Published in: Brain, behavior, and immunity behavior, and immunity, 2008-11, Vol.22 (8), p.1138-1145
• Main Authors: Yang, Hyunwon, Dixit, Vishwa D, Patel, Kalpesh, Vandanmagsar, Bolormaa, Collins, Gary, Sun, Yuxiang, Smith, Roy G, Taub, Dennis D
• Format: Article
• Language: English
• Subjects: Age Factors; Aging; Allergy and Immunology; Analysis of Variance; Animals; Enzyme-Linked Immunosorbent Assay; Female; Ghrelin; GHS-R; Growth Hormone - metabolism; IGF-1; Immunohistochemistry; Insulin-Like Growth Factor I - metabolism; Male; Mice; Mice, Transgenic; Organ Size; Pit-1; Pituitary; Pituitary Gland - growth & development; Pituitary Gland - metabolism; Prolactin; Prolactin - blood; Prolactin - metabolism; Psychiatry; Receptors, Ghrelin - genetics; Receptors, Ghrelin - metabolism; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger - metabolism; Thymus; Transcription Factor Pit-1 - metabolism
• ISSN: 0889-1591; 1090-2139
• DOI: 10.1016/j.bbi.2008.06.003

Abstract In mice and in rats, reduced levels of the growth hormone secretagogue receptor (GHS-R1a) results in reduced body weight and lower levels of serum insulin-like growth factor I (IGF-I). However, the mechanism leading to these impairments has not been elucidated. Studies in primary cultures of pituitary cells from very young mice have shown that GHS-R1a agonists, including ghrelin, increase expression of the pituitary-specific transcription factor (Pit-1) that is critical for differentiation of pituitary cells into somatotrophs, lactotrophs, and thyrotrophs. Hence, we hypothesized that ablation of Ghsr would reduce Pit-1 expression and as a consequence reduce growth hormone (GH) production explaining the lower body weight of Ghsr−/− mice. Here, we now show that Pit-1 mRNA levels are significantly lower in the pituitary gland of Ghsr−/− mice compared to wild-type littermates and also with advancing age. This Pit-1 loss is associated with reduced GH mRNA and fewer GH producing cells. To determine whether reduced GH is caused by reduced expression of Pit-1 in Ghsr−/− mice, we also measured prolactin (PRL) expression in the pituitary gland and in the circulation. PRL mRNA was significantly reduced in Ghsr−/− mice compared to wild-type littermates and fewer cells expressed PRL. The reduction in expression of both GH and PRL is consistent with a Pit-1 regulated pathway and demonstrates that the GHS-R has an important role in the pituitary gland as a modulator of Pit-1 expression and provides a possible mechanism to explain the lower plasma IGF-1 and modestly reduced body weight exhibited by Ghsr−/− mice. We also believe that lower systemic and lymphoid hormone expression may also account, in part, for the enhanced thymic involution and reduced thymic output in Ghsr−/− mice.